ETOPOSIDE INJECTION
ETOPOSIDE INJECTION
Dormant
DIN Number
02239961
Drug Class
Human
Market Date
Oct 20, 2014
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02239961
AIG Number0114567002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ETOPOSIDEActive
Strength: 20 MG / ML
Monograph: ETOPOSIDE